Analystreport

Emergent Biosolutions Inc (NYSE: EBS) was given a new $72.00 price target on by analysts at Laidlaw. They now have a "buy" rating on the stock.

Emergent Biosolutions, Inc.  (EBS) 
Last emergent biosolutions, inc. earnings: 4/30 04:08 pm Check Earnings Report
US:NYSE Investor Relations: investors.emergentbiosolutions.com